Pharmaceuticals Acquisitions in Canada

Avista Healthcare Partners announced it has completed the acquisition of Trillium Health Care Products from New Water Capital for undisclosed terms. Trillium, a Brockville, Ontario-based contract development and manufacturing organization (CDMO), specializes in branded over-the-counter products across multiple dosage forms for consumer healthcare and pharmaceutical customers. Avista plans to support Trillium’s growth and use it as a platform for potential strategic acquisitions.

Apotex Pharmaceutical Holdings Inc. announced the closing of its acquisition by an affiliate of funds advised by SK Capital Partners, LP. Following the transaction, Allan Oberman was appointed President and CEO to help transform Apotex into a Canadian-based global health company.

DW Healthcare Partners (DWHP) announced the completion of its investment in Bio Agri Mix, a Canadian manufacturer and distributor of medicated feed additives and water-soluble medications for livestock. The partnership will support Bio Agri Mix’s continued growth and expansion of its product portfolio in the animal health pharmaceutical market.

H.I.G. Capital announced that one of its affiliates has completed the acquisition of BioVectra Inc., a contract development and manufacturing organization (CDMO) focused on active pharmaceutical ingredients and intermediates. BioVectra serves global pharmaceutical and biotech customers with cGMP outsourcing solutions and operates facilities in Charlottetown, Prince Edward Island and Windsor, Nova Scotia, Canada.